Clinical Trial Update: Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma

View source ↗

Summary

This clinical trial update describes an expanded treatment protocol using panobinostat in combination with bortezomib and dexamethasone for relapsed or refracto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Panobinostat (Panobinostat)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Myeloma | Status: NO_LONGER_AVAILABLE